medigraphic.com
ISSN 0035-0052 (Impreso)

2017, Número 3

<< Anterior

Rev Mex Pediatr 2017; 84 (3)


Consenso para el manejo de la falla hepática aguda en pediatría

Reyes-Cerecedo A, Flores-Calderón J, Villasis-Keever MÁ, Ortiz-Galván RC, Jean-Aurelus P, Cuervo-Moreno E, Fernández-Mezo N, Oliver-García EF, Torres-Díaz JS, Vallejo-Pérez AM, Martínez-Muñiz I, Cabrera-Salas R, Siordia-Reyes AG, Bolaños-Téllez B, Monroy-Teniza ZA, Ledesma-Ramírez S, Rodríguez-González P, Pacheco-Rosas DO

Idioma: Español
Referencias bibliográficas: 28
Paginas: 120-128
Archivo PDF: 355.96 Kb.


FRAGMENTO

La falla hepática aguda (FHA) se caracteriza por presencia de daño hepático, coagulopatía, ictericia y encefalopatía; en niños, es poco común, pero con desenlace fatal hasta en un 70%.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Squires RH, Ng V, Romero R, Ekong U, Hardikar W, Emre S et al. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology. 2014; 60(1): 362-398.

  2. Singh T, Gupta N, Alkhouri N, Carey WD, Hanouneh IA. A guide to managing acute liver failure. Cleve Clin J Med. 2016; 83(6): 453-462.

  3. Leise MD, Poterucha JJ, Kamath PS, Kim WR. Management of hepatic encephalopathy in the hospital. Mayo Clin Proc. 2014; 89(2): 241-253.

  4. Lidbury JA. Getting the most out of liver biopsy. Vet Clin North Am Small Anim Pract. 2017; 47(3): 569-583.

  5. Ravindran S, Hancox SH, Howlett DC. Liver biopsy: past, present and future. Br J Hosp Med (Lond). 2016; 77(2): 90-95.

  6. Pokorska-Śpiewak M, Kowalik-Mikołajewska B, Aniszewska M, Pluta M, Marczyńska M. Is liver biopsy still needed in children with chronic viral hepatitis? World J Gastroenterol. 2015; 21(42): 12141-12149.

  7. Kaur S, Kumar P, Kumar V, Sarin SK, Kumar A. Etiology and prognostic factors of acute liver failure in children. Indian Pediatr. 2013; 50(7): 677-679.

  8. Bernal W, Wendon J. Acute liver failure. N Engl J Med. 2013; 369(26): 2525-2534.

  9. Lutfi R, Abulebda K, Nitu ME, Molleston JP, Bozic MA, Subbarao G. Intensive care management of pediatric acute liver failure. J Pediatr Gastroenterol Nutr. 2017; 64(5): 660-670.

  10. He GL, Feng L, Duan CY, Hu X, Zhou CJ, Cheng Y et al. Meta-analysis of survival with the molecular adsorbent recirculating system for liver failure. Int J Clin Exp Med. 2015; 8(10): 17046-17054.

  11. Oh SH, Kim KM, Kim DY, Kim Y, Song SM, Lee YJ et al. Improved outcomes in liver transplantation in children with acute liver failure. J Pediatr Gastroenterol Nutr. 2014; 58(1): 68-73.

  12. Schilsky ML, Honiden S, Arnott L, Emre S. ICU management of acute liver failure. Clin Chest Med. 2009; 30(1): 71-87, viii.

  13. Orban JC, Walrave Y, Mongardon N, Allaouchiche B, Argaud L, Aubrun F et al. Causes and characteristics of death in intensive care units: a prospective multicenter study. Anesthesiology. 2017; 126(5): 882-889.

  14. Rovira A, Alonso J, Córdoba J. MR imaging findings in hepatic encephalopathy. AJNR Am J Neuroradiol. 2008; 29(9): 1612-1621.

  15. Poniachik Teller J, Contreras Basulto J. MARS in fulminant liver failure. The Chilean experience. Gastroenterol Hepatol. 2005; 28(2): 95-99.

  16. Lexmond WS, Van Dael CM, Scheenstra R, Goorhuis JF, Sieders E, Verkade HJ et al. Experience with molecular adsorbent recirculating system treatment in 20 children listed for high-urgency liver transplantation. Liver Transpl. 2015; 21(3): 369-380.

  17. Ahmad J, Friedman SL, Dancygier H. Mount Sinai expert guides. Hepatolog. Chichester, West Sussex, UK: John Wiley & Sons Ltd; 2014.

  18. Liu JP, Gluud LL, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for liver failure. Cochrane Database Syst Rev. 2004; (1): CD003628.

  19. Schaefer B, Schmitt CP. The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children. Pediatr Nephrol. 2013; 28(9): 1763-1769.

  20. Nevens F, Laleman W. Artificial liver support devices as treatment option for liver failure. Best Pract Res Clin Gastroenterol. 2012; 26(1): 17-26.

  21. Olin P, Hausken J, Foss A, Karlsen TH, Melum E, Haugaa H. Continuous molecular adsorbent recirculating system treatment in 69 patients listed for liver transplantation. Scand J Gastroenterol. 2015; 50(9): 1127-1134.

  22. Devictor D, Desplanques L, Debray D, Ozier Y, Dubousset AM, Valayer J et al. Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology. 1992; 16(5): 1156-1162.

  23. Ray S, Rogers L, Pagel C, Raman S, Peters MJ, Ramnarayan P. PaO2/FIO2 ratio derived from the SpO2/FIO2 ratio to improve mortality prediction using the pediatric index of mortality-3 score in transported intensive care admissions. Pediatr Crit Care Med. 2017; 18(3): e131-e136.

  24. Berndtson AE, Sen S, Greenhalgh DG, Palmieri TL. Estimating severity of burn in children: Pediatric Risk of Mortality (PRISM) score versus Abbreviated Burn Severity Index (ABSI). Burns. 2013; 39(6): 1048-1053.

  25. Donnelly MC, Hayes PC, Simpson KJ. The changing face of liver transplantation for acute liver failure: Assessment of current status and implications for future practice. Liver Transpl. 2016; 22(4): 527-535.

  26. Devictor D, Tissieres P, Durand P, Chevret L, Debray D. Acute liver failure in neonates, infants and children. Expert Rev Gastroenterol Hepatol. 2011; 5(6): 717-729.

  27. Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology. 2012; 55(3): 965-967.

  28. Cicciarelli J, Iwaki Y, Mendez R. The influence of donor age on kidney graft survival in the 1990s. Clin Transpl. 1999; 335-340.




2020     |     www.medigraphic.com